I note "broad label" often referred to as the expectation by PR does not necessarily mean DMOAD.
"Slowing the progression of OA with some possible added protection of the structural integrity of the knee" may be how it is marketed.
If we do strike a deal with a major pharma does anyone really think they won't seek to maximize their own sales/profits, break down regulatory barriers, mitigate against interference or tricks, etc.?
This thinking seems to be at odds with the more likely scenario of PAR being taken out early at a fraction of its long term intrinsic value to the acquirer. This IMO is our biggest concern on OA-008 + peer review dropping.
- Forums
- ASX - By Stock
- PAR
- Ann: Paradigm AGM Presentation
Ann: Paradigm AGM Presentation, page-117
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
31.0¢ |
Change
0.035(12.7%) |
Mkt cap ! $108.4M |
Open | High | Low | Value | Volume |
27.5¢ | 31.0¢ | 27.5¢ | $108.9K | 371.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 17420 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 0.300 |
2 | 54067 | 0.295 |
2 | 6448 | 0.290 |
2 | 60208 | 0.285 |
2 | 100000 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 17420 | 5 |
0.315 | 112073 | 3 |
0.320 | 120163 | 4 |
0.325 | 3050 | 2 |
0.330 | 29123 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |